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Abstract 
Chondrosarcoma is one of the most common malignant bone tumors in adults. It use to affect upper arm, pelvis and 
thigh bone. A wide surgical extirpation represent the gold standard to treat this disorder. In fact, radiotherapy and 
chemotherapy are no useful. Interestingly, chondrosarcoma is rare in head and neck (HNCS) and extremely uncom-
mon during pregnancy.  Thus, there is a lack of evidence about the proper treatment in these cases. A wide surgical 
extirpation is also considered the most effective procedure in HNCS. There are no consistent evidences about the he 
role of radiation and chemotherapy.  In view of that, the present study describes a case of juxtacortical mandibular 
chondrosarcoma affecting a 28-year-old pregnant woman. After a multidisciplinary analysis of the case, we decided 
to treat the patient with a wide surgical resection and and immediately reconstruction.
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Introduction
Chondrosarcoma is a malignant cartilaginous tumor 
characterized by the formation of cartilage, but not of 
bone, by tumor cells (1). The most common location of 
this tumor are pelvis, extremities and ribs. The inciden-
ce of involvement of head and neck sites varies from 
5% to 12% (2). Larynx, thyroid cartilage, and arytenoids 
are the most common localizations of injurie. Moreover, 
chondrosarcomas could affect other areas of the cranio-
facial area such as the mandible, maxilla, nose, parana-
sal sinuses, base of the skull and nasopharynx. Never-
theless, chondrosarcoma is rare in head and neck. This 
malignant neoplasm cause only 0.1% of all head and 
neck neoplasms. In the head and neck, usually begins 
between the fourth and the seventh decades of life (3). 
The etiology appear to be related with the uncontrolled 
proliferation of Merkel Cells (embryonic remains). 
In this line, chondrosarcoma is also uncommon during 
pregnancy. In fact, only 10 cases of gestational chondro-
sarcomas was described in the literature during the last 
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25 years. Only one of these cases affected craniofacial 
area (4). The effect of pregnancy on growth features of 
chondrosarcomas remains unclear. Some studies suggest 
a possible growth-enhancing effect of altered hormone 
levels on various bone tumors. 
Due to the rarity of head and neck chondrosarcoma 
(HNCS) there are no established treatment protocols. 
Many of the current treatment approaches stem from 
protocols developed and tested for chondrosarcomas 
of other more frequent locations. However, the adequa-
te surgical resection remains the gold standard for the 
treatment of the jaw chondrosarcoma. In fact, the real 
role of chemotherapy and radiotherapy is still contro-
versial (5). 
Case Report
The article describes a case of a juxtacortical chondro-
sarcoma of the mandible affecting a 28-year-old woman. 
Interestingly, she was 31 weeks pregnant.
More in detail, the patient referred the onset of a pain-
less lump in the mandibular symphysis at the emergency 
department of our hospital. The lesion appeared spon-
taneously a few weeks earlier. No trismus, paresthesia 
or other symptoms were reported by the patient. At the 
exploration, the mass was fixed to the jaw without mo-
bility. Moreover, the patient related a rapid growth (Fig. 
1). Against this backdrop, the emergency physician aler-
Fig. 1: Clinical image of mandibular chondrosarcoma. Patient re-
ferred a rapid growth of the injury. She noted a small lump three or 
four weeks before. The aggressiveness of the lesion is evident.
ted the maxillofacial surgeon on call. Consequently, the 
patient was referred to maxillofacial outpatient clinic. 
Once there, we decided to carry out a diagnostic biop-
sy. This test evidenced the presence of chondrosarcoma 
cells in the specimen. Therefore, after an accurate analy-
sis of the case the diagnosis of juxtacortical mandibular 
chondrosarcoma was obtained. Considering that patient 
was almost 8 months pregnant at the time, a non-contrast 
CT scan of cervicofacial area was performed when the 
biopsy result were obtained. Labor was induced at 36 
weeks of pregnancy. One week later, we completed the 
diagnostic process with a contrast CT scan. Mandibular 
bone was extensively affected by the tumor. Jaw was in-
volved from 43 to 36 (Fig. 2). 
Thus, after the presentation of all the evidence we clas-
sified the cancer as cT3N0M0. In the oncological com-
mittee of our hospital, we decided to treat the case with a 
wide surgical resection and inmediately reconstruction. 
Surgery was performed three weeks after delivery. The 
extension of the injury obliged to perform a mandibu-
lectomy from the tooth 44 to 37, including the skin of 
mental and submental region. The reconstruction was 
performed by using a microsurgical scapular flap (Fig. 
3). Postoperative examination confirmed the diagnosis 
of juxtacortical HNCS moderately differentiated with 
resection margins free. The patient has no clinical signs 
of recurrence 18 months after surgery.
Fig. 2: Sagittal CT images of mandibular chondrosarcoma.
Fig. 3: Post-op panoramic x-ray of jaw reconstruction.
Discussion
The incidence of CHS in the mandible is rare. Only 
30 cases have been reported to date (MEDLINE 1966-
J Clin Exp Dent. 2017;9(5):e723-5.                                                                                                                                                           Mandibular Chondrosarcoma during pregnancy
e725
2016). The clinical behavior is variable. However, the 
majority (80%-90%) are low-grade malignant tumors. 
The median age of presentation varies between 17 to 75 
years and it occurs more often in females (6). Whereas, 
chondrosarcoma is more common in men if all cervi-
cofacial area is considered (HNCS). According to the 
literature, the time required to make a diagnosis varies 
generally between 6 and 24 months. This delay might 
be due to confusion with other inflammatory patholo-
gies (7). However, in our case diagnostic was very quick 
(approximatively 1 month after first symptom). In fact, 
the tumor showed a rapid and progressive growth. This 
might be related to hormonal shifts caused by pregnan-
cy. There is only one documented case of HNCS during 
pregnancy (8). Hence, there is insufficient evidence to 
characterize this pathology.
Panoramic x-ray and CT or magnetic resonance imaging 
are essentials for a proper diagnosis and analysis of the 
tumor extension. Additionally, an incisional biopsy is 
needed to complete the diagnosis. In this line, an aspira-
tion biopsy is not recommended. 
A number of other lesions should be considered in the 
differential diagnosis such as Epulis, Haemangioma and 
fibrosarcoma (7). 
Wide surgical resection is currently the gold standard to 
treat HNCS. Resection must be wide (> 2-3 cm). Close 
or positive margins are related with an increased risk of 
recurrence. Local recurrence is the main cause of death. 
Other factors that influence the global survival are repre-
sented by stage at diagnosis, histopathological grade and 
location. In general, lymph node metastases and distant 
metastases are infrequent. Survival rates for HNCS ran-
ge between 44 and 88 % (9). 
Postoperative radiotherapy and systematic chemothera-
py might be useful to improve disease free survival and 
overall survival. Notwithstanding, there are no consis-
tent evidences about the effectiveness of these treatment. 
Chondrosarcoma appears to be resistant to radiation 
treatment. Postoperative radiotherapy is recommended 
only for high-grade tumors and for unresectable lesions. 
On the other hand, an effective chemotherapy regimen 
does not exist at the moment (10).
A wide surgical resection is also the first choice of 
treatment in skeletal chondrosarcoma of during preg-
nancy (4). In our case, we treat the patient with surgical 
resection and immediately reconstruction. Considering 
the wide surgical margins and lack of evidence about 
the effectiveness of radiotherapy and chemotherapy we 
decided to treat the patient only with surgery. Moreover, 
these treatment are not very effectively in skeletal chon-
drosarcoma. No signs of recurrence or metastases were 
evidenced 18 months after surgery. Despite this a close 
follow up is mandatory. Tumor might provoke metasta-
ses several years after diagnosis. 
Resuming, this case stresses the importance of wide sur-
gical resection. However, no evidences exist and more 
research is needed in this field. This particularly applies 
to HNCS during pregnancy. 
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